Virology and HIVAIDS

With the continuous emerging of new strains of viruses, virologists played a major role in finding new advancements to fight against them. They became the most complex organisms causing dreadful diseases. One among them is the HIV-1, a retrovirus causing AIDS making the immune system the primary target. It has been around 20 years, our scientists researching on this HIV and though antiretroviral drugs reduced the mortality rate, still lot more research to be done to eradicate this completely. Join us and share your thoughts alos on this hot topic

In 2019, the global antiviral drugs market size was valued at $56.4 billion and is expected to register a CAGR of 2.3% over the estimated period. Around 1,848 pipeline products are specifically in development for treating the viral infections. Global HIV Drug Market was valued at USD20,448 million in 2015 and is predicted to reach USD26,458 million by 2022, at a CAGR of 3.7% during the forecast period of 2016-2022. 

Sub-Tracks

• Molecular virology of HIV & Viral Therapy
• Viral genomes
• Viral Pathogenesis and Immunity
• Viral Evolution and Emerging Viruses
• HIV/AIDS Epidemiological Statistics
• Anti-HIV Drugs 
• Animal Models of HIV Infection and Disease

Market Analysis: projecting a steady and robust expansion. Instead of the previously cited figures, a more current analysis indicates the market, valued at $2.96 billion in 2024, is expected to reach $5.31 billion by 2030, reflecting a substantial CAGR of 10.3%. This upward trajectory is primarily fueled by a paradigm shift towards more accessible testing methods, such as point-of-care (POC) and at-home self-testing kits, which are gaining traction due to their convenience, privacy, and speed. Furthermore, the market is being propelled by increased government initiatives and global health campaigns, including those by UNAIDS, which are intensifying efforts to meet ambitious testing and treatment targets. Technological innovations, such as the integration of molecular diagnostics and multiplex platforms that can test for multiple infections simultaneously, are also key drivers, enhancing the accuracy and efficiency of diagnostic tools. This combination of rising awareness, supportive policies, and advanced technology is set to redefine the landscape of HIV diagnostics and significantly boost its market value in the coming years.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/virology-and-hivaids